Should you buy Aptose Biosciences (APTO) in 2020?
Aptose Biosciences (APTO) is a science-driven biotechnology company advancing first-in-class agents to treat life threatening hematologic malignancies, which includes acute myeloid leukemia (AML), myelodysplastic syndrome